I didn’t get that from the ann Longshot. My interpretation was a focus on ebitda with no mention of EPS. Did I miss something?
Given acquisitions, divestments and earn outs in the pipeline, EPS may remain flat on the back of increased EBITDA.
Otherwise, I agree you general sentiment that good days still ahead of this business.
- Forums
- ASX - By Stock
- IMS
- Ann: Market Update
Ann: Market Update, page-8
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online